{
    "code": "52026140",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026140",
    "time": "2018-06-22 04:35:28",
    "許可證字號": "衛部藥輸字第026140號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/28",
    "發證日期": "102\/08\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202614005",
    "中文品名": "賀樂維 0.5毫克\/毫升注射液",
    "英文品名": "Halaven 0.5mg\/ml Solution for injection",
    "適應症": "(一) 轉移性乳癌\r\nHALAVEN 用於治療轉移性乳癌患者且曾接受過至少兩種針對轉移性乳癌之化學治療。先前之治療應包括anthracycline和taxane用於輔助性或轉移性治療。\r\n(二) 脂肪肉瘤\r\nHALAVEN用於治療無法手術切除或轉移性脂肪肉瘤，患者先前應至少接受一次含anthracycline之全身化療。",
    "劑型": "270注射劑",
    "包裝": "2毫升小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "Eribulinmesylate"
    ],
    "限制項目": "",
    "申請商名稱": "0407901100  衛采製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F259101000  BSP PHARMACEUTICALS",
        "製造廠廠址": "VIA APPIA KM 65,561 04013 LATINO SCALO (LT), ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F130304000  EISAI MANUFACTURING LTD.",
            "製造廠廠址": "EUROPEAN KNOWLEDGE CENTRE, MOSQUITO WAY, HATFIELD, HERTFORDSHIRE, AL10 9SN UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "次包裝廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002610",
            "成分名稱": "Eribulin mesylate",
            "含量描述": "",
            "含量": "1.1300000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Halaven仿單上傳 (site change)-106-11-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026140&Seq=004&Type=9"
        },
        {
            "title": "Halaven中文仿單-105-11-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026140&Seq=002&Type=9"
        },
        {
            "title": "Halaven標籤上傳(原)-106-11-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026140&Seq=009&Type=8"
        },
        {
            "title": "Halaven外盒上傳 (site change)-106-11-01(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026140&Seq=008&Type=8"
        },
        {
            "title": "Halaven外盒-105-12-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026140&Seq=005&Type=8"
        }
    ]
}